Profluent

Don’t miss the latest episode of The Bio Report podcast, where our CBO Hilary Eaton, PhD joined Daniel Levine for a wide-ranging conversation about the role of #GenerativeAI in drug development, our OpenCRISPR-1 molecule and why we made it open-source. 👉 https://lnkd.in/gkD4iAEt #AI #CRISPR #OpenCRISPR #ProteinDesign #Podcast

Yesterday on BBC’s #AIDecoded, our CEO Ali Madani joined Christian Fraser and Priya Lakhani OBE to share how we’re using #AI to design entirely new #CRISPR medicines from scratch, and bring cures to people suffering from historically incurable genetic diseases. Check out the full segment here👇 https://lnkd.in/eMUFdUUv

Join us next week at BIO, June 3-6 in San Diego, where our CBO Hilary Eaton, PhD will be giving a presentation on our AI-powered approach to #geneediting. We can't wait to connect with you to discuss how we're shaping the future of biotechnology. Find us on the One-on-One Partnering System. See you there! #BIO2024

Check out Ron Leuty’s piece in the San Francisco Business Times on how Profluent is driving a new chapter of drug discovery with generative AI 👇    https://lnkd.in/eUsU4F-e #AI #GenerativeAI #ProteinDesign #CRISPR

Don’t miss us this week at #PEGSBoston, where we’ll be detailing our success in building custom-designed, functional gene editors from scratch using #LLMs, plus teasing some antibody data. Poster on Thursday, talk on Friday. Details below 👇 #AI #GenerativeAI #ProteinDesign #CRISPR

Great to be at the American Society of Gene & Cell Therapy Annual Meeting last week, and to see so many people at the oral presentation on #OpenCRISPR given by our VP and Head of Gene Editing, Peter Cameron. It’s truly an exciting time in the field of #AI and gene editing 🚀  #ASGCT24

At this week’s American Society of Gene & Cell Therapy’s 27th Annual Meeting, Peter Cameron will be giving an oral presentation highlighting the potential of our AI-powered approach for custom-building gene editors. Details below 👇 #ASGCT2024 #AI #GenerativeAI #ProteinDesign #CRISPR

“It’s really just scratching the surface. It’s showing that it’s possible to design these complex systems with machine-learning models.” -CEO Ali Madani In Nature Portfolio, Ewen Callaway covers how we’re using protein language design to create highly performant CRISPR gene editors, and what this could mean for medical applications 👇 https://lnkd.in/eynnJJw6

#ICYMI, this week we published a research paper detailing our achievement of successfully editing the human genome with a gene editing system fully designed by #AI for the first time. We invite you to read our new blog where the paper’s co-first authors Jeffrey Ruffolo, Stephen Nayfach, Joseph Gallagher, and Aadyot Bhatnagar delve further into how we were able to leverage #LLMs to build our AI generated editor OpenCRISPR-1 and our decision to publicly release this gene editor to spur further research and innovation in the field. 👇 https://lnkd.in/gGs-Qgt7

Our CEO Ali Madani spoke with Cade Metz at The New York Times about our landmark achievement in editing the human genome with our AI-generated gene editor, OpenCRISPR-1. Check out the piece to learn more about our OpenCRISPR initiative and what its open-source release could mean for the future of CRISPR medicine development 👇 https://lnkd.in/dreNP-GE